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ABSTRACT 
 
Julie Ann Elpers: Outcomes with a Four-Implant Supported Monolithic Zirconia Dental Prosthesis in the Maxilla 
(Under the direction of Lyndon F. Cooper) 
 
 
A one-arm prospective clinical study undertaken in the spring of 2012 in the Department of Graduate 
Prosthodontics aimed to document the treatment efficacy, fabrication and maintenance requirements, and change 
in patient quality of life with a 4-implant supported fixed prostheses for the edentulous maxilla. Four endosseous 
implants 6-8mm in length allowed patients previously confined to complete dentures or overdentures to enjoy the 
comfort and confidence of a fixed, esthetic dental prosthesis. The study sought to espouse a consistently 
minimally-invasive approach to implant therapy and provide patients with a specific CAD/CAM zirconia prosthetic 
design.  The manuscripts that follow represent two distinct objectives and outcomes of this unique healthcare 
intervention: to describe the biological, technical and clinical complications of this treatment modality, and to 
assess oral health-related quality of life before and after treatment. 
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CHAPTER I 
 
OUTCOMES WITH A FOUR-IMPLANT SUPPORTED MONOLITHIC ZIRCONIA DENTAL PROSTHESIS IN THE MAXILLA: 
IMPLANT AND PROSTHETIC COMPLICATIONS 
INTRODUCTION 
Edentulism is a chronic disability that interferes with everyday tasks such as eating, speaking, and 
socializing (Roumanas 2009).  Well-constructed, tissue-borne complete dentures remain an economical and 
relevant treatment option for the edentulous patient (Cooper 2009), yet complete dentures are not without 
disadvantages and there exist a significant proportion of patients who desire completely fixed prosthetics. 
The long-term success (Adell et al 1990, Romeo et al 2004, Jemt et al 2006) and widespread acceptance of 
dental implants in the edentulous maxilla has made the full-arch fixed prosthesis a choice alternative to 
conventional tissue-supported complete dentures and implant-retained removable appliances.  Surgical protocols 
for the placement, loading, and restoration of osseointegrated implants in the edentulous maxilla have been 
described and evaluated in the literature (Lambert et al. 2009). 
A multitude of approaches have been successfully used to rehabilitate the edentulous, atrophic maxilla 
(Toljanic et al 2009, Bidra et al 2012). While six or more implants were commonly advocated (Norton and Ferber 
1999, Kinsel and Lamb 2003), four implants have been reported to be sufficient to support full-arch loading in the 
maxilla provided the anterior-posterior spread allows for cantilevers of less than 10mm anteriorly and posteriorly 
(Maló et al 2005, Jensen et al  2010).  However, continued bone resorption and pneumatization of the sinuses 
often necessitates a modified approach to implant therapy to ensure sufficient distribution of the four fixtures. 
Broadly, these approaches may be arranged into three categories, and may be used in combination: 1) 
augmentation of the edentulous ridge and/or sinus, 2) placement of dental implants into the zygoma or 
pterygomaxillary region, and 3) use of iplants with limited length/height.  
The  use of “short implants” (defined often as less than 8.5mm in length) as a treatment modality for 
patients who otherwise would be required to undergo vertical bone augmentation procedures (such as sinus lift, 
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or vertical augmentation by particulate or block grafting) continues to be an area of research requiring well-
designed clinical trials with long-term follow-up (Atieh et al 2012).  Preliminary results (Felice et al 2011) from a 
short-term study comparing 5-8.5mm implants vs. autogenous grafting procedures followed by 11.5mm implant 
placement suggest a lower rate of postoperative complications with short implants and similar implant success 
rates. Roughened-surface short implants do not show higher failure rates than implants >10mm, with one meta-
analysis reporting implant survival rate in the range of 89.6%-100%, and no correlation between implant length 
and odds of failure (Sun et al. 2011).  Additionally, shorter implants (8-9mm) have been shown to be successful in 
the long term (10 year) time horizon,  and surface, location, prosthetic modality and bone quality do not seem to 
impact failure rates  (Romeo et al 2006, Atieh et al 2012, Metens et al 2012).   
Despite implant survival rates of 95-99%, long term data indicate survival rates for screw-retained fixed 
prostheses in the maxilla to be 82-84%, with complication-free survival as low as 9% (Mertens and Steveling 2011a 
and 2011b; Fischer and Stenberg 2011). A systematic review of 281 one-piece implant-supported complete dental 
prostheses (mean exposure time of 9.5 years) determined a rate of prosthetic complication to be 24.6% per 100 
restoration-years. The cumulative rates of "prosthesis free of complications" after 5 and 10 years were 29.3% and 
8.6%, respectively. The most common technical complication reported in the same systematic review was chipping 
of the veneering material, occurring 33.3% at 5 years and 66.6% at 10 years (Papaspyridakos et al 2012). Recent 
advances in materials and prosthesis design employing monolithic zirconia as well as lithium disilicate (Pozzi et al 
2013, Limmer et al 2014) have reported far fewer incidences of chipping of the veneering material over the 1-3 
year timeframe.  
The cost of an implant-retained or implant-supported prosthesis has been calculated to be between 5 and 
12 times more expensive than a conventional denture (MacEntee and Walton 1998).  To justify this expense, as 
well as subsequent maintenance expenses, data must exist to indicate that the implant-supported prosthesis 
provides benefit to the patient congruent with the added expense.  Bassi et al (2013) recently highlighted the 
paucity of data to support clinical decision making in terms of initial and maintenance costs for prosthodontic care 
and their bearing on patient perceptions of benefit and satisfaction.  To date, immediate full-arch implant-
supported rehabilitation in patients who had previously worn tissue-supported dentures has been shown to yield 
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significant improvement in patient satisfaction and factors related to eating comfort, function and esthetics 
(Dierens et al 2009, Erkapers et al 2011, Limmer et al 2014). 
The primary objectives of this one-arm prospective pilot study are to evaluate the survival of dental 
implants of limited width/length placed in native bone in the atrophic maxilla, and the long-term prosthetic 
outcome of fixed implant- supported maxillary complete prosthesis made of monolithic zirconia.  The null 
hypothesis, therefore, can be stated as:  a four-implant supported, screw-retained maxillary dental prosthesis 
made of monolithic zirconia will have implant and prosthetic complication rates comparable to those previously 
reported for implant-supported reconstructions in the maxilla.  
MATERIALS AND METHODS 
The details of the proposed study were submitted to the University of North Carolina at Chapel Hill (UNC-CH) 
Office of Human Research Ethics for IRB review, and the study was approved in March, 2012 (IRB# 12-0447).  A 
total of 65 patients were screened from the patient pool at the UNC-CH School of Dentistry, as well as the 
community at large who responded to an online posting on the School’s website. Twenty patients who met the 
following inclusion/exclusion criteria were consecutively enrolled between April and October, 2012.  
Inclusion Criteria 
 between 18-80 at time of enrollment 
 good physical health (ASA Class I or II) 
 edentulous in the maxilla or have a terminal dentition of eight or fewer teeth 
 maxillary vertical bone height of at least 6 mm and width of 4mm in the selected implant sites  
 no history of radiotherapy in head and neck region  
 willing to give informed consent 
Exclusion Criteria  
 poor physical health or uncontrolled medical condition (ASA Class III or IV) 
 heavy smokers (in excess of 10 cigarettes/day) 
 vertical bone height less than 6mm and less than 4mm in width in any of the implant sites  
 severe Angle’s class II/III jaw relationships  
 inadequate vertical space for the definitive prosthesis 
 history of radiotherapy in head and neck region 
 issues in accepting a removable prosthesis (unwilling to wear dentures, severe gag reflex, etc.)  
 known alcohol and/or drug abuse  
 patient with unrealistic esthetic expectations 
 any other conditions that contraindicate dental implant therapy. 
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All patients with a terminal dentition were edentulated and allowed to heal for 3 months under an immediate 
denture. The remaining edentulous patients underwent fabrication of a new maxillary removable complete 
denture to optimize esthetics and function and aid in treatment planning for the future fixed implant-supported 
prosthesis.  The maxillary denture was duplicated in radioopaque acrylic (BiocrylX, Great Lakes Orthodontics, 
Tonawanda, NY) to fabricate a radiolographic/surgical guide (Figure 1.1a and b).  An 8cmx8cm Cone Beam 
Computed Tomography (CBCT) volume (Sirona Orthophos XG 3D Dental CT Scanner, New York, NY), was obtained.  
Implant planning software (SimplantPro version 15, Materialise Dental, Waltham, MA) was used to map desired 
sites having both adequate bone for implant placement (6mm height x 4mm width) and congruence with tooth 
set-up (Figure 1.2).  The surgical guide was marked and drilled by hand.   
    
Figure 1.1 a and b. Duplicated maxillary complete denture placed for radiographic/surgical guide in (a) single-
arch case opposing natural dentition and (b) dual arch case.  
 
 
Figure 1.2.  Example of planned implant sites in native bone. Implants intruded for both surgical convenience in 
obtaining adequate ridge width and ideal placement for prosthetic bridge design/tooth set-up. 
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Under local anesthesia, sites were marked with the surgical guide and a crestal incision made to visualize 
the maxillary ridge (Figure 1-3a); all necessary alveolectomy was performed using a rongeur and/or e-cutter bur in 
a straight handpiece under copious irrigation.  Four AstraTech Osseospeed™TX  implants (Dentsply, Waltham, MA) 
were placed by standard protocol in planned locations of the maxilla and cover screws placed finger-tight (Figure 
1.3b).  Should a patient present with inadequate bone volume for implant placement in a particular site at the time 
of surgery, a plan was made for either a) placement into an alternate site, or b) the implant was placed in the 
planned site and any resulting dehiscence or fenestration was grafted by means of autogenous bone and bone 
substitute (Bio-Oss, Geistlich, Princeton, NJ) placed and secured with a collagen membrane (Bio-Gide, Geistlich, 
Princeton, NJ). Incisions were closed with 4-0 chromic gut suture (Figure 1.3c), the denture relined with soft tissue 
conditioner (Coe-comfort, GC America, Alsip, IL), and the patient followed up after two weeks to assess healing.  
 
   
 
Figure 1.3a-c. Surgical approach for implant placement: (a) crestal incision made following marking of sites with 
surgical guide, (b) placement of cover screws, (c) incisions closed completely for at least 12 weeks of healing 
under complete denture.  
 
The dental implants were buried under the oral mucosa for three months following placement to allow 
for healing and osseointegration, during which time the patient continued to wear the complete maxillary denture.  
After at least 12 weeks of healing, second-stage surgery was conducted under local anesthesia. The implants were 
evaluated for stability and the appropriate AstraTech UniAbutment or Angled Abutment (Dentsply, Waltham, MA) 
was selected and torqued to 20 Ncm. At this point or in the weeks following, an abutment-level impression was 
made for fabrication of the master cast (Figure 1.4a-c). 
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Figure 1.4a-c.  Final impression technique. UniAbutments torqued into implants following second-stage surgery 
(a), abutment-level impression pick-ups placed (b), and pick-ups secured into surgical guide washed with PVS (c).  
 
As a first step in fabrication of the final prosthesis, a conversion prosthesis (Figure 1.5a) was made by 
picking up UniAbutment temporary cylinders (AstraTech, Dentsply, Waltham, MA) in the maxillary denture with 
quick-set autopolymerizing acrylic (Pro-Tech PLUS, Boynton Beach, FL).  In cases where the denture was thin or the 
patient requested to remain in a removable prosthesis, this step was omitted.  A mock-up of the final tooth set-up 
on the master cast was sent to the dental laboratory for digital design of the definitive prosthesis (Figure 1.5b). A 
milled resin prosthesis was fabricated, tried in, and adjusted for optimal phonetics, esthetics, and function (Figure 
1.5c).  This milled resin prosthesis was returned to the dental laboratory for refinement of the digital design and 
final fabrication of the monolithic zirconia prosthesis (Microdental, Morrisville, NC or ZirkonZahn GMBH, Gais, 
Italy). (Figure 1.5d). 
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Figure 1.5a-d.  Prosthesis fabrication. The conversion prosthesis (a) is fabricated as both an interim restoration 
and to guide laboratory design of the final prosthesis (b) for this dual-arch case.  Resin mock-ups are milled and 
tried in (c), returned to the laboratory, and the definitive monolithic zirconia prosthesis is milled, stained, 
sintered, and gingival porcelain applied (d). 
 
At the delivery appointment, passive fit of the definitive prosthesis was evaluated using the one-screw 
test.  All bridge screws were torqued to 15Ncm and access holes covered with cotton pellets and light-cure 
composite (Filtek, 3M ESPE).  Any necessary intraoral occlusal adjustments were carried out sequentially with blue, 
pink, and grey polishing wheels (Dialite, Brasseler, Savannah, GA). A post-op Panorex was exposed at this point and 
evaluated (Figure 1.6a and b).  
  
 
Figure 1.6a and b.  Postoperative panorex for single arch (a) and dual arch (b) cases.  
 
A hard acrylic occlusal guard was fabricated (Great Lakes Orthodontics, Tonawanda, NY) and fitted to the 
patient at a follow-up appointment 2-4 weeks after delivery.  A 12-, 24-, and 60-month examination and 
radiographic follow-up after prosthesis delivery will be completed to evaluate implant and prosthesis survival, 
complications and patient quality of life. 
RESULTS 
Sixty-five patients who were edentulous or had terminal dentition in the maxilla were screened.  Twenty 
patients were enrolled:  fifteen (75%) were edentulous at baseline, the remaining five had a terminal dentition.  
Only three terminal dentition patients had more than 5 teeth in the maxilla. Two of the five patients who were 
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edentulated had severe (>5mm) periodontal attachment loss around most remaining teeth. Eleven patients (55%) 
had been edentulated more than 2 years prior to enrollment.  
The study population (Table 1.1) can be described as mostly white (70%), non-smoking (80%), and non-
diabetic (85%). Twelve patients were female.  In addition, nine patients had an existing or planned four-implant 
supported mandibular prosthesis made of monolithic zirconia.  The remaining cohort had either entirely natural 
dentition (n=4), or some combination of implant restorations and natural dentition (n=7). 
Table 1.1 Demographic data for the study population.  
Demographic variable (n=20) N Percent 
Age (mean=57.8, σ = 11.9) 
 
 
 
Under 50 4 20.0% 
 
 50-65 11 55.0% 
 
>65 5 25.0% 
Gender 
   
 
Female 12 60.0% 
 
Male 8 40.0% 
Race 
   
 
White 14 70.0% 
 
Black 5 25.0% 
 
Hispanic 1 5.0% 
Maxillary dentition at baseline 
 
 
 
Edentulous 15 75.0% 
 
Terminal (≤5 teeth) 2 10.0% 
 
Terminal (>5 teeth) 3 15.0% 
Time since maxillary edentulation 
 
 
 
Within last 2 years 9 45.0% 
 
>2 years ago 11 55.0% 
Mandibular dental status 
 
 
 
Edentulous 9 45.0% 
 
Dentate  11 55.0% 
Smoker (<10 cigarettes/day) 
 
 
 
Nonsmoker 16 80.0% 
 
Smoker 4 20.0% 
Diabetic (controlled, A1c<6.5) 
 
 
 
No 18 90.0% 
  Yes 2 10.0% 
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Twenty patients underwent implant therapy in healed ridges using a two-stage approach (total number of 
AstraTech Osseospeed TX implants placed: 85).  Nearly half (48.7%) of implants were 4.0x6mm in dimension; the 
remaining proportion were predominantly 4.0x8mm.  There was no dimensional predilection for anterior/posterior 
sites (Table 1.2).  Almost all (94.1%) of implants were placed in native bone; five implants were placed in 
previously-augmented sinus grafts with at least 6 months of healing prior to placement. Two patients received a 
fifth implant in a central incisor site at the time of initial implant placement (to minimize anterior cantilever). 
Panoramic radiographs were exposed following implant surgery and following final prosthesis placement. 
The radiographs were evaluated for change in crestal bone height around implants. Those implants that 
demonstrated a change in bone height on Panorex of at least 1mm were labeled “at risk” for future complications. 
These findings are also summarized in Table 1.2. 
Table 1.2. Location and dimension of implants placed, as well as location and dimension of implants determined 
to be “at risk” following loading (defined as bone height change ≥1mm following placement), as assessed by 
postoperative Panorex.  
 
  Implant Dimensions   
    4x6mm 4x8mm Total 
Anterior sites (#6-11) 19 22 41 
 
Implants at risk 3 2 5 
Posterior sites(#3-5, #12-14) 21 20 41 
 
Implants at risk 1 1 2 
Total Implants loaded 40 42 82 
  Total implants at risk 4 3 7 
There were two early implant failures (2.4%), discovered at the time of second-stage surgery or shortly 
thereafter (at the time of final impression). In another patient, implant malposition due to limited bone volume 
prevented its incorporation into the prosthetic design, and the implant was buried (Table  1.3).  Therefore, 82 
implants were loaded with fixed, full-arch prostheses. Most implants (87.8%) were loaded prior to final fabrication 
of monolithic zirconia restoration with an acrylic conversion or interim prosthesis. The average time since implant 
loading was 9.1 months (range 1.2-14 months). 
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Table 1.3. Description of implant failures and complications. 
Patient Implant 
complication 
Implant 
position 
Implant 
dimension 
Timing of 
complication 
Rescue procedure Treatment 
failure? 
3 failure to integrate #4 4.0x6mm at time of final 
impression 
implants placed #3, #5 No 
10 failure to integrate #10 4.0x8mm at second stage surgery implant placed #11 No 
15 improper position #9 4.0x8mm at time of prosthesis 
fabrication 
cover screw placed and 
implant buried 
No 
For each osseointegrated implant, a 20- or 45-degree Uniabutment, or AstraTech Angled abutment, was 
used. Twenty-degree UniAbutments of varying heights were placed in 70.7% of implants. Angle corrections were 
largely required in the anterior sites, while posterior sites more often required use of 45-degree abutments to aid 
in prosthesis draw (Table 1.4). 
Table 1.4. Description of number and type of abutment used, by location.   
      
20-degree 
UniAbutment 
45-degree 
UniAbutment 
Angled 
Abutment 
Anterior Implant sites 30 0 11 
n=41 
     Posterior implant sites 28 10 3 
n=41 
     Total     58 (70.7%) 10 (12.2%) 14 (17.1%) 
Twelve treatment visits were planned per study protocol, and included both intake and all surgical and 
prosthetic follow-ups.  Table 1.5 enumerates the number of additional visits required between final impression 
and prosthesis delivery, and complications with conversion prostheses, milled resin interim prostheses, and try-in 
procedures.   
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Table 1.5. Complications with denture conversion prostheses, milled interim prostheses, and try-in resins, 
assessed by number of additional patient appointments outside 12-visit treatment protocol.  
 
Number of 
patients 
Median number of 
additional appointments 
per patient 
Total number of 
additional 
appointments 
Additional try-in of new denture set-up or 
lab-fabricated resin mock-up 
12 1 (range= 1-3) 21 
Abutment switch or new final impression 5 1 (range=0-1) 5 
Interim prosthesis fracture or complication 6 1 (range=1-5) 14 
Post-delivery adjustment 5 1 (range=1-2) 7 
    Total additional appointments   1.5 (range=0-8) 47 
To date, the average time since definitive prosthesis delivery is 3.5 months (range 0.9-7.8 months).  There 
has been one prosthetic complication observed in one patient, which was discovered at the post-insertion visit.  
The clinician noticed chipping of the porcelain veneering, which had not been noticed by the patient (Figure 1.7a).  
This patient, a bruxer, was one of three patients who received a monolithic zirconia prosthesis framework with 
facial porcelain veneering on the anterior 6 teeth.   
  
Figure 1.7 a and b.  Chipping of the veneering porcelain discovered by clinician at follow-up (a), and a clinical 
example of an uncomplicated monolithic zirconia prosthesis without veneering (b).  
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DISCUSSION 
The present study found a  high level of osseointegration and demonstrated no treatment failures with up 
to 1.3 years (mean: 9.1 months) of prosthetic loading and up to eight months after definitive monolithic zirconia 
prosthesis delivery.  Surgical revision for patients who experienced dental implant failures was managed by placing 
an implant into an adjacent site the very day or day following discovery of failed osseointegration. It should further 
be noted that both of the patients with primary failure of osseointegration of maxillary fixtures had a history of 
severe periodontitis and implant failure in the mandible.  
At the time of definitive prosthesis placement, all 82 implants were soundly integrated and without 
evidence of peri-implant infection or chronic inflammation around abutments. An initial assessment of bone level 
changes on Panorex was performed by visually comparing bone level around implants immediately following 
placement and after final prosthetic loading.  Generally, 8-12 months elapsed between these time points and the 
implants had been loaded for an average of 5.7 months (range: 0-11.8 months) with an interim or conversion 
prosthesis before delivery of the definitive prosthesis. Implants with bone level height changes of 1mm or more 
were noted to be “at risk.” This “at risk” description was applied to 7 implants in five patients (8.5% at implant 
level, 25% at the patient level), and no implant demonstrated more than 2mm of bone adaptation.  
Though this data is short term, it is certainly indicative of the possibility that a “minimally invasive” 
approach to implant therapy for a fixed, full-arch prosthesis may be of value.  There are many approaches to 
placement of dental implants in the atrophic maxilla, irrespective of final prosthetic design.  Maló et al (2011) 
discussed 5-year outcomes of a study cohort who underwent immediate loading in the maxilla on four implants: 25 
out of 221 patients lost 41 implants, giving a patient-level survival rate of 88.7% and an implant-specific survival 
rate of 95.8%.  These outcomes are remarkably consistent with implant outcomes in this investigation to date. If 
we are to operate on the premise that at least four dental implants are necessary for optimal reclamation of a 
functional dental arch (Maló et al 2005; Jensen and Adams 2009), three approaches to the atrophic maxilla can be 
broadly defined: bone grafting, employment of the zygoma or trans-sinus implants (Maló et al 2013), and use of 
implants with limited height/width.   
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There have been two randomized controlled trials designed to address the use of short implants as 
opposed to sinus augmentation for longer implants in the edentulous maxilla. Preliminary results from a short-
term study comparing the use of 5-8.5mm implants vs. autogenous iliac crest grafting and 11.5mm implants in the 
edentulous maxilla suggested a lower rate of postoperative complications with short implants and similar implant 
success rates. (Felice et al 2011). A second RCT used a split-mouth design to compare maxillary sinuses augmented 
with particulate porcine bone via a lateral window (implants placed simultaneously) with 4x6mm implants in 
native bone.   Of the 20 patients treated, 15 patients preferred short implants, whereas 5 patients treated with 
maxillary implants described both procedures as equally acceptable (Esposito et al 2012).   This was largely 
attributed to expedited treatment time and minimized surgical intervention. 
The rate of early implant failures (2.4%) observed in this study was consistent with previously-reported 
rates of failure for all types of short dental implants (Atieh et al 2012, Al-Hashedi et al 2014). Both patients who 
experienced these “early failures” were edentulous in the maxilla for at least two years and exhibited severe 
periodontal attachment loss around mandibular teeth.  Parel and Phillips (2011) enumerated risk factors for dental 
implant failure for a maxillary immediate-load protocol: opposing natural dentition, male gender, lack of bone 
density, the distal implant site, and parafunction. While this investigation is insufficiently powered to draw 
conclusions on risk factors for early implant failures, continued follow-up may reveal predictive factors for patients 
in whom this implant approach may be more risky.  
Zitzmann and Marinello (2000) enumerated three broad prosthetic approaches to implant therapy for the 
edentulous maxilla: implant-supported fixed partial dentures, the “hybrid” fixed [full-arch] implant restoration, 
and the removable overdenture.  The segmental fixed partial denture concept, applicable in cases of limited bone 
resorption, is often championed for retrievability and cleansibility despite higher treatment costs.  The full-arch 
implant supported fixed denture, broadly defined, is capable of restoring soft and hard tissue deficits in the 
edentulous maxilla.  However, there are two major challenges inherent in this prosthetic approach.  The first is the 
patient’s lip position on animation, lip support, and tonus of the orofacial muscles.  The prosthesis must be 
carefully designed to address these issues and provide optimum dental and facial esthetics.  The second major 
challenge involves the architecture of the prosthesis with respect to the palatal anatomy and implant position.  
Often, it is desirable to create a fixed prosthesis with a narrow intaglio to allow for access to hygiene around the 
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implants; however, the contour of the palatal prosthesis as it abuts the tissue is often incongruent with optimal 
phonetics and alveolar resorption may necessitate palatal positioning of the dental implants.  The removable 
overdenture, therefore, is often cited as a simple means by which to address these two contouring challenges and 
removes the additional oral hygiene difficulties inherent in fully implant-supported fixed restorations (Fortin et al 
2002).  An acrylic denture base more readily accommodates soft and hard tissue deficiencies and is generally 
considered less costly to replace.  
This study attempted to address the above challenges in fixed maxillary prostheses and employed a CAD-
CAM fabrication process with potential for decreased manufacture costs.  In terms of prosthesis design and 
fabrication, the complexity and variability in conversion, try-in, and number of adjustments for this particular 
approach cannot be underemphasized. The twelve treatment visits planned per study protocol allowed for a four-
appointment complete denture fabrication process and one resin-try-in for the lab-fabricated prosthesis.  
However, the length of time during which patients were wearing an interim implant supported restoration (often 
>6 months) necessitated multiple repairs, and in most cases multiple esthetic/phonetic try-ins were necessary.  In 
five cases the abutment selection required revision following CAD and a new final impression was needed.  
Generally, the reason for delay in prosthesis fabrication was due to the intricacies of converting an “analog” 
denture design into an esthetic, phonetic, and functional milled resin, and converting the approved resin mock-up 
into a final esthetic prosthesis acceptable to the patient.  A previous study (Limmer et al 2014), assessed the value 
of a mandibular implant-supported fixed denture made of monolithic zirconia in the mandible.  Issues with 
phonetics, tissue seam morphology, and patient esthetic expectations inherent in maxillary fixed prostheses were 
not addressed.  While this CAD/CAM approach to dental prosthesis fabrication is certainly promising, there exists a 
certain need for clinical attention to detail in maxillary full-arch prostheses, and additional treatment visits at the 
try-in phase certainly underscores this issue.  
Regarding the choice of dental material selected for this investigation, monolithic zirconia suprastructures 
were selected based on the potential for good esthetic outcome without veneering, and high strength.  Zirconia 
has a monoclinic crystal structure from room temperature to 1170°C, tetragonal from 1170°C to 2370°C, and cubic 
at temperatures above 2370°C. Upon cooling, a volume expansion of 3% to 5% is associated with the transition of 
the tetragonal to monoclinic phase. Oxides (such as magnesia, ceria, yttria and calcium) are added to zirconia to 
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stabilize the tetragonal phase during cooling: in particular, yttria-stabilized zirconia has been developed specifically 
for dental purposes. Transformation toughening refers to the transition from stabilized tertragonal to monoclinic 
phase as a result of stress, surface treatment, or temperature changes (Al-Amleh, 2010).  The volume expansion 
resulting from the transformation can suppress cracks, increase toughness, or induce compressive surface stresses. 
While transformation toughening would appear to address concerns with crack propagation and fatigue, 
an accelerated ageing phenomenon is known as low-temperature degradation (LTD) causes a decrease in physical 
properties by spontaneous phase transformation of the zirconia crystals from the tetragonal phase to the weaker 
monoclinic phase in the presence of water (Flinn et al 2012).  Conceivably, should a critical proportion of the bulk 
material transition to the monoclinic phase, this would result in spontaneous catastrophic failure of the material.  
Much has been made of the possibility of LTD: however, no data exist to demonstrate the frequency or time 
course over which this may occur, or clinical relevance.  
In this study, there were no observed fractures or failure of the monolithic zirconia component of the 
implant-supported fixed dentures.  While seventeen patients received purely monolithic prostheses without 
veneer, three patients received prostheses with porcelain veneering along the facial of the incisors as means of 
optimizing esthetics. One of these three patients, a bruxer, exhibited chipping of the veneer after only four weeks 
in function.  This underscores the major issues with veneer porcelain fracture reported in the literature (Guess et al 
2012).  
Because of the aforementioned limitations with regard to removal and hygiene with implant supported 
fixed “hybrid” prostheses, it is worthwhile to note that zirconia has been found to be more biocompatible than 
other ceramics, heat-cured resin, titanium, and metal alloys (Nakamura et al 2010).  In vitro studies have 
demonstrated significantly lower bacterial adhesion to polished zirconia surfaces when compared to titanium 
(Rimodini et al 2004 and Scarano et al 2010).  This is particularly important when the prosthesis is in direct contact 
with the gingival tissue, as with an implant-supported full-arch maxillary prosthesis. This question has previously 
been addressed for edentulous resin, metal, and acrylic prostheses.  Kanao et al (2013) found that milled titanium 
was superior to composite resin in terms of plaque adhesion to the intaglio surface of the fixed dental prosthesis 
and resulted in lower levels of mucosal blood flow (and  thereby inflammation).  Another recent study (Abi Nader 
et al 2014) found that acrylic maxillary four-implant supported fixed dentures exhibited an average of 28% of the 
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tissue-surface area covered with plaque after 6 months despite rigorous oral hygiene instruction. This is certainly 
of interest in the context of this study, as by and large patients wore an acrylic or resin interim prosthesis for 6 
months or more following second-stage surgery. Given the fact that 8.5% of implants experienced some bone loss 
from placement to definitive prosthesis delivery (up to 12 months), it is not lost on the investigators that the 
manner in which patients are provisionalized may certainly matter.  Anecdotally, a marked decrease in mucosal 
inflammation and edema was noted between the day of prosthesis placement and follow-up 2-4 weeks later.  As 
clinicians and laboratories seek to improve and optimize the workflow in fabricating CAD/CAM zirconia 
restorations, this provisionalization phase may be reduced in importance.  Yet, for this investigation, it remains to 
be seen whether the unanticipated complications in prosthesis try-in, design, and long term use of resin and acrylic 
provisionals will have a significant negative effect on long-term tissue and implant health.   
Certainly, this study served to describe a novel treatment approach and the challenges therein.  While the 
approach to implant therapy was indeed conservative with regard to implant number, dimension and loading, 
design and management of the monolithic zirconia prosthesis proved complicated.  All enrolled patients currently 
have implant-supported full-arch monolithic zirconia prostheses supported by four or five implants delivered and 
functioning, demonstrating a high level of clinical success in the short term.  It is the objective of the accompanying 
investigation to assess the patient-centered outcomes of this particular treatment modality.  
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CHAPTER II 
 
COMPLICATIONS WITH A FOUR-IMPLANT SUPPORTED MONOLITHIC ZIRCONIA DENTAL PROSTHESIS IN THE 
MAXILLA: PATIENT-CENTERED OUTCOMES 
INTRODUCTION 
Due to increased public health initiatives related to oral healthcare, it has previously been observed that 
edentulism is declining at a rate of about 1% per year in industrialized countries. While this fact may suggest that 
there will be a decreasing need for treatment interventions for edentulous patients, the average life expectancy 
and total population are increasing, and therefore the number of edentulous patients is remaining stable or 
slightly increasing.  By 2020, is predicted that there will be approximately 37.9 million edentulous elderly adults in 
the United States (Douglass 2002).   Edentulism is a chronic disability that interferes with everyday tasks such as 
eating, speaking, and socializing (Roumanas 2009).  Well-constructed tissue-borne complete dentures remain an 
economical and relevant treatment option for the edentulous patient (Cooper 2009), yet complete dentures are 
not without disadvantages and there exist a significant proportion of patients who desire completely fixed 
prosthetics. 
The cost of an implant-retained or implant-supported prosthesis has been calculated to be between 5 and 
12 times more expensive than a conventional denture (MacEntee and Walton 1998). To justify this expense, as 
well as subsequent maintenance expenses, data must exist to indicate that the implant-supported prosthesis 
provides benefit to the patient congruent with the added expense. Bassi et al (2013) recently highlighted the 
paucity of data to support clinical decision-making in terms of initial and maintenance costs for prosthodontic care 
and their bearing on patient perceptions of benefit and satisfaction.  To date, immediate full-arch implant-
supported rehabilitation in patients who had previously worn tissue-supported dentures has been shown to yield 
significant improvement in patient satisfaction and factors related to eating comfort, function and esthetics 
(Dierens et al 2009, Erkapers et al 2011). 
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Any healthcare intervention should be systematically evaluated for a measureable improvement to 
improve the health of an individual or population. To this end, an instrument must be able to describe the nature, 
direction, and magnitude of change, and experimental studies may be designed to identify predictor of change and 
control for confounders.  On a population scale, benefits include identification of sub-groups within the population 
requiring care, monitoring of at risk groups, targeting of financial resources and monitoring outcomes of clinical 
interventions.  
Locker (1988) employed an existing model of oral health to define seven function domains and relate 
them hierarchically: disease can lead to impairment, then functional limitation, and ultimately physical, 
psychologic, and social disability/discomfort.  Based on this, The Oral Health Impact Profile (OHIP-49) was 
specifically designed to measure the impact of oral health on psychosocial well-being (Slade and Spencer 1994). 
This questionnaire consists of 49 items that cover seven specific domains: functional limitation, physical pain, 
psychological discomfort, physical disability, psychological disability, social disability, and handicap. At the present 
time, measures of oral health-related quality of life have been mainly used in descriptive population studies, 
predominantly in older adults.  These studies have established that the measures are reliable and show good 
concurrent validity when judged against clinical, subjective and behavioral criteria.  A few studies (Awad et al 2000, 
Allen et al 2006, Brennan et al 2010) have employed versions of OHIP (including the shortened form, OHIP-14) to 
compare OHR-QoL between treatment groups: for example, conventional dentures vs. two-implant overdentures, 
or overdentures vs. implant-supported fixed prostheses.  A recent review (de Souza et al 2013) highlighted the 
need for increased attention to patient-centered outcomes in removable prosthodontics trials.  
Zitzmann and Marinello (2000) enumerated three broad prosthetic approaches to implant therapy for the 
edentulous maxilla: implant-supported fixed partial dentures, the “hybrid” fixed [full-arch] implant restoration, 
and the removable overdenture. Additionally, there are wide variations in approach to implant fixture number, 
distribution, placement, and loading.  Irrespective of the nature of surgical intervention, the patient is provided 
with a dental prosthesis that may have certain advantages and disadvantages.  Because rehabilitation of the 
edentulous maxilla is often based on a treatment “endpoint” (reestablishment of establish function, phonetics, 
and esthetics), it is difficult to predict which prosthetic approach will be ideal for a specific patient segment.  With 
one notable exception in the literature (Heydecke et al 2003), within- subject comparison is often impossible.  
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Therefore, careful assessment and comparison of OHR-QoL pre- and post-treatment is of importance and provides 
a measure of treatment effectiveness for a given approach.  Additionally, an understanding of patient factors as 
they relate to OHR-QoL pre- and post-treatment may further aid in clinical decision making.  This study aims to 
assess baseline, post-treatment and change in OHR-QoL as measured by OHIP-49 for a specific treatment modality: 
placement of four dental implants into native bone by two-stage approach, and restoration with a monolithic 
zirconia implant-supported fixed denture.   
MATERIALS AND METHODS 
The details of the proposed study were submitted to the University of North Carolina at Chapel Hill (UNC-
CH) Office of Human Research Ethics for IRB review, and the study was approved in March, 2012 (IRB# 12-0447).  A 
total of 65 patients were screened from the patient pool at the UNC-CH School of Dentistry, as well as the 
community at large who responded to an online posting on the School’s website. Twenty patients who met the 
following inclusion/exclusion criteria were consecutively enrolled between April and October, 2012.  
Inclusion Criteria 
 between 18-80 at time of enrollment,  
 good physical health (ASA Class I or II) 
 edentulous in the maxilla or have a terminal dentition of eight or fewer teeth 
 maxillary vertical bone height of at least 6 mm and width of 4mm in the selected implant sites  
 no history of radiotherapy in head and neck region  
 willing to give informed consent 
Exclusion Criteria  
 poor physical health or uncontrolled medical condition (ASA Class III or IV) 
 heavy smokers (in excess of 10 cigarettes/day) 
 vertical bone height less than 6mm and less than 4mm in width in any of the implant sites  
 severe Angle’s class II/III jaw relationships  
 inadequate vertical space for the definitive prosthesis 
 history of radiotherapy in head and neck region 
 issues in accepting a removable prosthesis (unwilling to wear dentures, severe gag reflex, etc.)  
 pregnant women 
 known alcohol and/or drug abuse  
 patient with unrealistic esthetic expectations 
 any other conditions that contraindicate dental implant therapy. 
Each enrolled patient completed an OHIP-49 questionnaire at baseline. All patients with a terminal maxillary 
dentition (Figure 2.1a) were edentulated and allowed to heal for 3 months in an immediate denture. The 
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remaining edentulous patients (Figure 2.1b and c) underwent fabrication of a new maxillary removable complete 
denture to optimize esthetics and function and aid in treatment planning for the future fixed implant-supported 
prosthesis.  A  Cone Beam Computed Tomography (CBCT) volume (Sirona Orthophos XG 3D Dental CT Scanner, 
New York, NY) and implant planning software (SimplantPro version 15, Materialise Dental, Waltham, MA) was used 
to plan implant sites.  
         
Figure 2.1a-c.  Examples of baseline dentition for included patients: (a) natural teeth with terminal dentition in 
the maxilla, (b) existing maxillary edentulous condition opposing at least 5 natural teeth, (c) existing maxillary 
and mandibular edentulism.  
 
Four AstraTech Osseospeed™TX  implants (Dentsply, Waltham, MA) were placed by standard protocol in 
planned locations of the maxilla.  Incisions were sutured and implants were completely covered for at least 12 
weeks of submucosal healing. Postoperatively, the denture was relined with soft tissue conditioner (Coe-comfort, 
GC America, Alsip, IL), and the patient was seen for two-week follow-up to assess healing.  
Following healing, second-stage surgery was conducted under local anesthesia, implants were evaluated for 
stability, and the appropriate AstraTech UniAbutment or Angled Abutment (Dentsply, Waltham, MA) was selected 
and torqued to 20 Ncm. An abutment-level impression was made for fabrication of the master cast, and a mock-up 
of the final tooth set-up on the master cast was sent to the dental laboratory for digital design of the final 
prosthesis. A milled resin try-in prosthesis was fabricated, tried in, and adjusted for optimal phonetics, esthetics, 
and function.  This milled resin was returned to the dental laboratory for final fabrication of the monolithic zirconia 
prosthesis (Microdental, Morrisville, NC or ZirkonZahn GMBH, Gais, Italy).  
The definitive prosthesis (Figure 2.2a and b) was evaluated for fit and then delivered to the patient. A 
hard acrylic occlusal guard was fabricated (Great Lakes Orthodontics, Tonawanda, NY) and fitted to the patient at a 
follow-up appointment 2-4 weeks after delivery.  At this time, the follow-up OHIP-49 questionnaire was 
administered and patients were asked to answer the items based on their current dental status. A 12-, 24-, and 60-
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month examination and radiographic follow-up after prosthesis delivery will be completed to evaluate implant and 
prosthesis survival, complications and patient quality of life. 
 
   
 
Figure 2.2a and b. Examples of maxillary single arch (a) and dual arch (b) monolithic zirconia implant-supported 
fixed dentures.  
 
Two methods were used for OHIP-49 scoring: the severity score was calculated as the sum total of 
responses on an ordinal scale (0-4) for the 49 items. The response “very often” was scored as 4 and “never” was 
scored as 0, meaning that severity scores range from 0-196 with “0” considered ideal. The extent score was a 
count of the number of items to which the response “very often” or “fairly often” was given (range 0-49).  In 
addition, items were scored according to functional domain to attempt to identify which parameters of OHR-QoL 
were most important at baseline and post-treatment. Statistical analysis of OHIP-49 data was carried out using IBM 
SPSS Statistics for Windows, Version 22.0 (IBM Corp, Armonk, NY).  No correction for multiple tests was used as 
the baseline and post-treatment observations were generally one year apart.  Because of the small sample size and 
highly variable responses, normality in OHIP-49 scores could not be assumed and nonparametric tests were 
applied when assessing for differences in median OHIP-49 severity and extent scores at the two time points and 
between demographic groups.  Univariate ANOVA was applied, however, when examining variance in the change 
in severity and extent scores at baseline and post-treatment. Significance level was set at 0.05.  
RESULTS 
Sixty-five patients who were edentulous or had terminal dentition in the maxilla were screened.  Twenty 
patients were enrolled:  fifteen (75%) were edentulous in the maxilla at baseline, the remaining five had terminal 
dentition.  Only three patients with terminal dentition had more than 5 teeth in the maxilla. Two of the five 
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patients who were edentulated had severe (>5mm) periodontal attachment loss around most remaining teeth. 
Eleven patients (55%) had been edentulated more than 2 years prior to enrollment. 
The study sample (Table 2.1) can be further described as mostly white (70%), non-smoking (80%), and 
non-diabetic (85%). Twelve patients were female.  In addition, nine patients had an existing or planned four-
implant supported mandibular prosthesis made of monolithic zirconia.  The remaining cohort had either entirely 
natural dentition (n=4), or some combination of implant restorations and natural dentition (n=7).  
Table 2.1 Demographic data for the study population.  
Demographic variable (n=20) N Percent 
Age (mean=57.8, σ = 11.9) 
 
 
 
Under 50 4 20.0% 
 
 50-65 11 55.0% 
 
>65 5 25.0% 
Gender 
   
 
Female 12 60.0% 
 
Male 8 40.0% 
Race 
   
 
White 14 70.0% 
 
Black 5 25.0% 
 
Hispanic 1 5.0% 
Maxillary dentition at baseline 
 
 
 
Edentulous 15 75.0% 
 
Terminal (≤5 teeth) 2 10.0% 
 
Terminal (>5 teeth) 3 15.0% 
Time since maxillary edentulation 
 
 
 
Within last 2 years 9 45.0% 
 
>2 years ago 11 55.0% 
Mandibular dental status 
 
 
 
Edentulous 9 45.0% 
 
Dentate  11 55.0% 
Smoker (<10 cigarettes/day) 
 
 
 
Nonsmoker 16 80.0% 
 
Smoker 4 20.0% 
Diabetic (controlled, A1c<6.5) 
 
 
 
No 18 90.0% 
  Yes 2 10.0% 
 
Twenty patients underwent implant therapy in healed ridges using a two-stage approach (total AstraTech 
Osseospeed TX implants placed: 85).  Almost all (94.1%) of implants were placed in native bone; 5 implants were 
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placed in two patients with previously-augmented sinus grafts with at least 6 months of healing prior to 
placement. Two early implant failures (2.4%) were discovered at the time of second-stage surgery or shortly 
thereafter (at the time of final impression). In another patient, implant malposition due to limited bone volume 
prevented its incorporation into the prosthetic design and the implant was buried. Therefore, 82 implants were 
loaded with fixed, full-arch prostheses. Most implants (87.8%) were loaded prior to final fabrication of monolithic 
zirconia restoration with an acrylic conversion or interim prosthesis. To date, average time since implant loading is 
9.1 months (range 1.2-14 months); average time since definitive prosthesis delivery is 3.5 months (range 0.9-7.8 
months).   
At baseline, the median OHIP-49 severity score was 59 (range: 5-161), and median extent score was 9 
(range: 0-38).  The median post-treatment severity score was 8 (range: 0-29), median post-treatment extent score 
was 0 (range: 0-4). Related-samples Wilcoxon signed rank test demonstrated significant differences between 
baseline and post-treatment OHIP-49 severity and extent scores (p=0.001 for both cases, 2-sided test).  
Five variables were assessed for differences in severity and extent scores: age group (under 50, 50-65, 
over 65), gender, edentulous vs. terminal dentition at baseline, time since maxillary edentulation (within last 2 
years), and mandibular dental status (Tables 2.2 and 2.3). No statistically significant differences in OHIP-49 severity 
or extent scores at baseline or post-treatment between groups separated by age group (independent samples 
Kruskal-Wallis test), gender, edentulous/terminal dentition, or time since edentulation (independent-samples 
Mann-Whitney U test).  At baseline, patients edentulous in the maxilla opposing natural dentition had significantly 
higher OHIP-49 severity and extent scores when compared to those who had either existing or planned mandibular 
full-arch implant-supported fixed dentures (independent-samples Mann-Whitney U test).  However, there was no 
significant difference post-treatment between the single-arch and dual-arch cases in terms of OHIP-49 severity or 
extent.  
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Table 2.2. Baseline OHIP-49 severity and extent scores, by descriptive group. 
    N 
Median OHIP-49 
severity score p-value
a
 
Median OHIP-
49 extent score p-value
a
 
Age 
      
 
under 50 4 83.5 (12-161) 0.747
b
 15.0 (3-38) 0.486
b
 
 
50-65 11 60 (5-132) 
 
10 (0-28) 
 
 
>65 5 58 (11-86) 
 
5 (0-13) 
 Gender 
      
 
female 12 69.5 (5-161) 0.057
c
 11.5 (0-38) 0.082
c
 
 
male 8 48.5 (11-86) 
 
4 (0-13) 
 Maxillary dentition at baseline 
     
 
Edentulous 15 58 (5-161) 0.866
c
 8 (0-38) 0.553
c
 
 
Terminal dentition 5 60 (50-114) 
 
10 (5-25) 
 Time since maxillary edentulation 
     
 
Within last 2 years 9 53 (12-114) 0.331
c
 8 (0-25) 0.776
c
 
 
>2 years ago 11 77 (5-161) 
 
10 (0-38) 
 Mandibular dental status 
 
    
 
Fixed prosthesis 9 53 (5-86) 0.046
c
 5 (0-13) 0.046
c
 
  Dentate  11 77 (11-161)   13 (0-38)   
a
Exact significance (2-sided test) 
   bIndependent-Samples Kruskal-Wallis Test 
   cIndependent-Samples Mann-Whitney U Test 
   
Table 2.3. Post-treatment OHIP-49 severity and extent scores, by descriptive group. 
    N 
Median OHIP-49 
severity score p-value
a
 
Median OHIP-49 
extent score p-value
a
 
Age 
      
 
under 50 4 15 (15-18) 0.347
b
 0 (0-4) 0.521
b
 
 
50-65 11 6 (0-24) 
 
0 (0-2) 
 
 
>65 5 4 (0-29) 
 
0 (0-1) 
 Gender 
      
 
female 12 6 (0-29) 0.442
c
 0 (0-4) 0.657
c
 
 
male 8 13.5 (0-27) 
 
0 (0-2) 
 Maxillary dentition at baseline 
     
 
Edentulous 15 8 (0-29) 0.530
c
 0 (0-2) 0.665
c
 
 
Terminal dentition 5 10.5 (5-22) 
 
0 (0-4) 
 Time since maxillary edentulation 
     
 
Within last 2 years 9 16.5 (5-27) 0.020
c
 0 (0-4) 0.177
c
 
 
>2 years ago 11 3 (0-29) 
 
0 (0-0) 
 Mandibular dental status 
 
    
 
Fixed prosthesis 9 7 (0-24) 0.778
c
 0 (0-2) 0.0840
c
 
  Dentate  11 9 (0-29)   0 (0-4)   
a
Exact significance (2-sided test) 
   bIndependent-Samples Kruskal-Wallis Test 
   cIndependent-Samples Mann-Whitney U Test 
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Participants who had been edentulated within the past 2 years had a significantly higher median OHIP-49 
severity scores following treatment (Mann-Whitney U, p=0.02).  There were no other significant differences 
between OHIP-49 severity and extent scores following treatment between the descriptive groups.  
Data were further analyzed for differences in median OHIP-49 across the seven functional domains (Table 
2.4 and 2.5).  Generally, there were no differences between the descriptive groups at baseline and post-treatment 
for physical pain, physical disability, psychological disability, social disability, and handicap.  However, women and 
those who had natural dentition in the lower arch had significantly higher scores (Mann-Whitney U, p=0.02 and 
0.025, respectively) for the domain Psychological Discomfort.  Also, those who had natural dentition in the lower 
arch had significantly higher scores in the Functional Limitation domain when compared to those with lower 
implant-supported prostheses (Mann-Whitney U, p=0.025).  Following treatment, for patients who had been 
edentulous in the maxilla for less than 2 years, post-treatment OHIP-49 was significantly higher across the 
Functional Limitation Mann-Whitney U, p=0.002) and Physical Disability (Mann-Whitney U, p=0.02) domains.  
Finally, median change in OHIP-49 severity and score was found to be different for males (33, range=-6-
86) and females (62, range=38-146; Mann-Whitney U, p=0.031), and median change in OHIP-49 extent score was 
different among those edentulous in one arch only (13, rangle=0-38)compared to those with upper andlower ISFDs 
(3,  range -2-13; Mann-Whitney U, p=0.038). Univariate ANOVA (Table 2.6) found gender to be significant to 
explain the variance in OHIP-49 change from baseline to post-treatment for both scoring methods (p=0.041, R-
squared=0.211, and p=0.048, R-squared=.200), respectively. Additionally, post-treatment mandibular dental status 
was found to be explanatory for mean change in OHIP-49 extent score (p=0.026, R-squared 0.246). 
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Table 2.4.  Baseline OHIP-49 scores for domains with significant differences between descriptive groups. 
      OHIP-49 Domain* 
   
Functional Limitation 
(0-36) 
Psychological discomfort 
(0-20) 
    N Median  p-valuea Median p-valuea 
Age 
      
 
under 50 4 22.5 (4-33) 0.621
b
 14(0-20) 0.758
b
 
 
50-65 11 16 (3-31) 
 
9 (0-20) 
 
 
>65 5 11 (6-23) 
 
11 (0-14) 
 Gender 
      
 
female 12 21.5 (3-33) 0.115
c
 14.5 (0-20) 0.020
c
 
 
male 8 14.5 (4-23) 
 
5.5 (0-14) 
 Maxillary dentition at baseline 
     
 
Edentulous 15 16 (3-33) 0.800
c
 11 (0-20) 0.735
c
 
 
Terminal dentition 5 16 (13-29) 
 
9 (8-20) 
 Time since maxillary edentulation 
     
 
Within last 2 years 9 16 (4-29) 0.456
c
 8 (0-20) 0.230
c
 
 
>2 years ago 11 22 (3-33) 
 
14 (0-20) 
 Mandibular dental status 
 
    
 
Fixed prosthesis 9 16 (3-23) 0.025
c
 8 (0-14) 0.025
c
 
  Dentate  11 22 (6-33)   15 (0-20) 
 *For simplicity, only domains for which significant differences between groups were detected are shown.  
a
Exact significance (2-sided test) 
   bIndependent-Samples Kruskal-Wallis Test 
   cIndependent-Samples Mann-Whitney U Test 
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Table 2.5.  Post-treatment OHIP-49 scores for domains with significant differences between descriptive groups. 
      OHIP-49 Domain* 
   
Functional Limitation 
(0-36) 
Physical Disability 
(0-36) 
    N Median  p-valuea Median p-valuea 
Age 
      
 
under 50 4 6 (5-6) 0.206
b
 3 (2-7) 0.357
b
 
 
50-65 11 3 (0-8) 
 
1 (0-7) 
 
 
>65 5 2 (0-10) 
 
2 (0-1) 
 Gender 
      
 
female 12 3 (0-6) 0.272
c
 2 (0-10) 0.351
c
 
 
male 8 5 (0-10) 
 
5 (0-7) 
 Maxillary dentition at baseline 
     
 
Edentulous 15 2 (0-10) 0.262
c
 2 (0-10) 0.665
c
 
 
Terminal dentition 5 5 (3-6) 
 
2.5 (0-7) 
 Time since maxillary edentulation 
     
 
Within last 2 years 9 6 (3-10) 0.002
c
 5 (0-7) 0.020
c
 
 
>2 years ago 11 2 (0-5) 
 
0 (0-10) 
 Mandibular dental status 
 
    
 
Fixed prostheis 9 3 (0-8) 0.778
c
 2 (0-7) 0.840
c
 
  Dentate  11 4 (0-10)   2 (0-10)   
*For simplicity, only domains for which significant differences between groups were detected are shown.  
a
Exact significance (2-sided test) 
   bIndependent-Samples Kruskal-Wallis Test 
   cIndependent-Samples Mann-Whitney U Test 
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Table 2.6. Univariate ANOVA for changes in OHIP-49 severity and extent scores among descriptive groups.  
    N 
Mean change 
in OHIP-49 
severity score p-value
a
 
R-
squared 
Mean change 
OHIP-49 
extent score 
p-
value
a
 
R-
squared 
Age 
        
 
under 50 4 73.0 0.575 0.063 16.7 0.313 0.128 
 
50-65 11 60.8 
  
10.8 
  
 
>65 5 40.6 
  
5.6 
  Gender 
        
 
female 12 74.9 0.041 0.211 14.5 0.048 0.200 
 
male 8 33.1 
  
5.0 
  Maxillary dentition at baseline 
       
 
Edentulous 15 58.2 1.000 0.000 10.7 0.981 0.000 
 
Terminal dentition 5 58.2 
  
10.8 
  Time since maxillary edentulation 
       
 
Within last 2 years 9 42.2 0.163 0.105 8.1 0.340 0.051 
 
>2 years ago 11 71.2 
  
12.8 
  Mandibular dental status 
 
      
 
Fixed prosthesis 9 37.8 0.069 0.172 5.0 0.026 0.246 
  Dentate  11 74.9     15.4     
a
Exact significance (2-sided test) 
      
DISCUSSION 
In assessing the effectiveness of an oral health intervention, the OHIP-49 can be employed philosophically 
in a number of ways.  It provides descriptive information on OHR-QoL among the study cohort in their current 
dental state.  It can also be employed as means of measuring the impact of a treatment intervention by comparing 
pre-and post-treatment OHIP-49 scores (Awad et al 2000, Allen et al 2006, Erkapers et al 2011, Limmer et al 2014).  
Along with the primary objective of describing a novel treatment approach to the edentulous maxilla, this study 
sought to define, to some extent, a population for which this treatment approach may be most useful.  This is 
based on the premise that a significant decrease in OHIP-49 severity and extent scores is indicative of improved 
oral-health related quality of life and, by extension, overall quality of life.  
This study found that the median OHIP-49 severity score was 59 (range: 5-161) at baseline, and 8 (range: 
0-29) post-treatment.  The baseline and post-treatment medians were significantly different, and the median 
change in OHIP-49 score from baseline to post-treatment was 54 points (range: -6-194).  This is certainly indicative 
of an overall increase in OHR-QoL across the study population, but what is perhaps more remarkable is the 
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heterogeneity in responses. While all but one patient showed a positive change in baseline and post-treatment 
OHIP-49 severity scores, it is interesting to assess which aspects of OHR-QoL changed significantly over the course 
of the study, and for which patients the change was most marked. 
In the present study, the additive method was used to score the OHIP-49, wherein each item response 
was coded (0=never, through 4=very often) and the responses summed.  This was chosen from among the three 
most common methods of scoring in the literature: additive, simple count, and weighted score.  Simple count 
assigns a dichotomy to responses and sums the total number of items indicating disability/discomfort/limitation, 
etc. The weighted score is based on the Thurstone paired-comparison technique and assigns weights to items 
before summing them (five of the 49 items have a weight >2, with the balance weighted between 1.106-1.925).  
Allen and Locker (1997) found that additive and weighted scores are highly correlated and distinguish equally well 
between oral health status variables (edentulous/dentate, dry mouth, <20/≥20 teeth, self-rated oral health, 
perceived oral health need).   The correlations of scores and ability of the simple count method to distinguish 
between groups were far lower.  The authors further concluded that weighting did not substantially improve 
performance of the OHIP-49.   
The extent score is another important aspect to OHR-QoL assessment. At baseline, the median extent 
score was 9 (range: 0-38), and median post-treatment extent score was 0 (range: 0-4). It is reassuring to the 
clinician that the study population experienced an overall, consistent decrease in number of OHIP-49 items to 
which “very often” and “fairly often” were considered responses and by the end of the study only four patients 
had extent scores greater than zero.  This is indicative of the relatively low number of patients with significant 
OHR-QoL issues in the weeks post-treatment, and is probably to be somewhat expected in the 2 to 4  weeks 
following prosthesis delivery.  
Because of the wide variation in OHIP-49 severity and extent scores, it is important to consider baseline 
and post-op severity scores as they relate to the five descriptive variables of interest, and not simply the 
population “delta” over the treatment period.  Patients with significantly higher OHIP-49 severity and extent 
scores are considered to have worse OHR-QoL at the outset of treatment, and it is important to identify these 
patients. Our analysis indicated significantly higher OHIP-49 scores at baseline for patients edentulous only in the 
maxilla and having some combination of their own teeth (≥5) and implants restorations in the mandible.  
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Heterogeneity and the relatively small study sample make it difficult to speculate why this might be the case. 
When this baseline data was extended to functional domains, this same segment of patients had significantly 
higher scores for both Functional Limitation and Psychological Discomfort.  Additionally, women had significantly 
higher scores for the domain Psychological Discomfort.  This perhaps speaks to a greater treatment need among 
those edentulous in one arch only, and perhaps the psychological implications related to self-esteem and body 
image for women who are edentulous in the maxilla. 
 Post-treatment, however, these differences disappeared and new patterns emerged among the study 
cohort.  Again, this second assessment was conducted 2-4 weeks following insertion of the definitive zirconia 
prosthesis, which is by most standards to be considered within the post-treatment adjustment period in terms of 
phonetics, esthetics and function.  Following treatment, patients who had been edentulous in the maxilla for less 
than 2 years had a significantly higher median OHIP-49 severity scores.  When separated by domain, post-
treatment OHIP-49 was significantly higher for Functional Limitation and Physical Disability for these recently-
edentulated patients.  Logically, it is to be speculated that patients who had been edentulous for longer periods of 
time are likely better adapted to their disability.  
Finally, by assessing the change between baseline and post-treatment OHIP-49 severity and extent scores, 
it can be speculated for whom this treatment modality may have the greatest impact on OHR-QoL. Females had 
greater median change in OHIP-49 severity scores and those edentulous in one arch only had a greater median 
change in extent scores. Variance in the change in OHIP-49 for both scoring methods was explained by gender, 
with an effect size of .211 and .200 for severity and extent scores, respectively. The effect size (R-squared) found 
for singe vs. dual arch extent scores was 0.246. Cohen (1988) postulated that for the behavioral sciences, an effect 
size value of 0.2 should be considered small, 0.4 moderate, and 0.8 and above large.  By this, the effect of gender 
and opposing arch dentition on change in OHIP-49 scores is to be considered small for this study.  Still, these 
findings are not without significance and do indicate for whom this intervention may be most beneficial as 
measured by change in OHIP-49 severity and extent scores: women, and those edentulous in the maxilla with 
natural teeth in the lower arch. In all analyses of baseline, post-treatment, and change in OHIP-49 scores, there 
were no significant differences among age groups, and age was not a predictive factor for change in OHIP-49 score.  
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By pairing the OHIP-49 with some measure of patient satisfaction, or assessment of patient perception as 
to the benefit of treatment, the magnitude of change in OHIP-49 severity and extent score required for definitive 
improvement in OHR-QoL can be identified.  This minimal important difference  has been defined as the “the 
smallest difference in score in the domain of interest which patients perceive as beneficial and which would 
mandate, in the absence of troublesome side effects and excessive cost, a change in the patient's management” 
(Jaeschke et al 1989).  John et al (2009) sought to determine the measured, quantitative change in OHIP-49 that is 
indicative of a tangible, definitive change in quality of life as assessed by 5-point global assessment: “to what 
degree did you experience a change in your overall oral health status comparing your situation before treatment 
was started with the present status?”  The median change in severity score for the category “a little better,” was 
found to be 6 OHIP-49 units lower and for the category “a lot better” as 10 OHIP-49 units lower; for the category 
“a little worse” the median change was 11 points higher than baseline (though the sample was small).  Clearly the 
median change in OHIP-49 severity scores found in this study are far larger and suggest that overall the study 
population experienced definite improvement in overall oral health.  
Treatment experience and patient choice may certainly have bearing on OHIP scores, as Allen et al 
(2001b) noted significant improvement in edentulous patients who were treated according to their preferences. 
Since this was a one-arm study, all patients elected to the same treatment.  Still, it is worth bearing in mind that 
perhaps the differences identified in patient-centered outcomes between descriptive treatment groups in 
indicative of treatment selection being variable among patients with the same condition.  While we seek to 
optimize interventions for particular conditions (in this case, maxillary edentulism) and monitor patient-centered 
outcomes, it is certainly worthwhile to acknowledge a shift in paradigm from a single “ideal” treatment modality to 
identifying “for whom” a treatment may be most beneficial.  
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